Tilsotolimod

(Synonyms: IMO-2125)
Revisión del cliente

Based on 1 Customer Validation

Tilsotolimod (IMO-2125) is a TLR9 agonist. Tilsotolimod activates the TLR9 signaling pathway, triggers downstream pro-inflammatory and immunostimulatory pathways, enhances the uptake and killing of cancer cells, and induces adaptive immune responses. Tilsotolimod is applicable to research related to melanoma and colorectal cancer.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza : 99.46%
  • No. CAS: 1948266-37-2
  • Fòrmula: C223H284N74O115P22S22
  • Peso molecular:7228.00
  • Almacenamiento:

    -20°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Actividad biológica
  • Chemical Information
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Ver todos los productos específicos de isoformas Toll-like Receptor (TLR)

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00